Federal Reserve's Preferred Inflation Gauge Reaches Three-Year Peak
Money

Federal Reserve's Preferred Inflation Gauge Reaches Three-Year Peak

authorBy T. Harv Eker
DateJun 25, 2026
Read Time4 min

The latest data indicates that the Federal Reserve's favored inflation metric has climbed to its highest point in three years. This surge suggests that the central bank will likely maintain its current interest rate policy, while also considering potential increases if inflationary trends do not subside. The core Personal Consumption Expenditures (PCE) index, which excludes volatile energy and food prices, also rose, signaling a more widespread inflation challenge. This economic development presents a complex situation for the Fed as it navigates monetary policy.

Federal Reserve Grapples with Surging Inflation Amidst Economic Crosscurrents

Washington, D.C. – The Federal Reserve is facing mounting pressure as its preferred measure of inflation, the Personal Consumption Expenditures (PCE) index, recently reached a three-year high in May 2026. This significant increase underscores the ongoing challenges policymakers confront in achieving price stability. The headline PCE index advanced by 4.1% in May, up from 3.8% in April, aligning with market expectations. On a monthly basis, inflation saw a 0.4% rise, slightly less than anticipated but consistent with the previous month's figures.

Of particular concern to the Fed is the trajectory of the 'core' PCE, which strips out the volatile food and energy components. This crucial indicator climbed to 3.4% in May, surpassing April's 3.3% and marking its highest level since October 2023. The month-over-month core inflation rate also nudged up to 0.3% from 0.2%.

While rising energy prices have contributed to the overall inflationary trend, the persistent increase in core inflation signals a broadening of price pressures across the economy, a pattern that began in April and continued through May. Federal Reserve officials recently indicated their intention to keep interest rates stable throughout the year, yet the possibility of a rate hike remains on the table. Federal Reserve Chairman Kevin Warsh emphasized the central bank's commitment to bringing inflation back to its 2% target.

Despite Chairman Warsh's non-committal stance on immediate monetary policy changes, nine of his colleagues at the Federal Open Market Committee (FOMC) projected at least one rate increase this year, with six members foreseeing two or more hikes. Conversely, eight members favored maintaining current rates.

Adding to the complexity, recent geopolitical developments, such as a potential deal between President Trump and Iran, could significantly impact oil prices. A sharp decline in crude oil costs, like the 38.8% drop in West Texas Intermediate prices from their May peak, could lead to a negative month-over-month inflation print for June, according to Joseph Brusuelas, Chief Economist at RSM. However, Brusuelas cautions that core inflation may prove more resilient due to persistent service sector inflation, the lingering effects of tariffs on goods, pressures from AI infrastructure development, and anticipated defense spending.

Economist Thomas Ryan from Capital Economics believes that core PCE likely peaked in May, attributing a potential future decline to fading tariff impacts and lower oil prices affecting sectors like airline fares. Nevertheless, he anticipates a gradual reduction in core inflation from August onwards, suggesting the Fed will have little choice but to tighten policy given robust economic activity and a strong labor market. Ryan projects three rate hikes, a sentiment partially echoed by market expectations, which currently assign a 50% chance of a 25 basis point hike in September.

Deutsche Bank analysts anticipate two rate hikes this year, in September and December, citing the broad-based nature of current inflationary pressures beyond singular factors like tariffs and energy. Ellen Zentner, Chief Economic Strategist for Morgan Stanley Wealth Management, reinforced this view, stating that current inflation levels will compel the Fed to maintain its restrictive stance for an extended period until economic conditions permit a policy reversal.

The current economic landscape, characterized by persistent inflationary pressures and diverse expert opinions on the Federal Reserve's next steps, highlights the intricate balancing act required from central bankers. As a reporter covering these developments, it's evident that the path to a stable 2% inflation target is neither straightforward nor universally agreed upon. The interplay of geopolitical events, domestic economic indicators, and varying interpretations by economists creates a dynamic environment where vigilance and adaptability are paramount for both policymakers and market participants. The coming months will be crucial in determining whether the current inflationary surge is a temporary blip or a more entrenched trend, with significant implications for future interest rate decisions and overall economic stability.

More Articles
Money
Cloud Infrastructure Showdown: Alphabet vs. CoreWeave
This analysis delves into the competitive landscape of cloud computing, comparing tech giant Alphabet with the specialized AI cloud provider CoreWeave. It examines their business models, growth trajectories, and valuation metrics to determine which company might offer a more compelling investment opportunity, catering to different investor preferences for stability versus high growth potential in the evolving AI infrastructure market.
By Bola SokunbiJun 25, 2026
Money
Leading Investors Divest, Yet Stocks Continue to Rise: An Analysis
Despite prominent investors like Stanley Druckenmiller, David Tepper, and Carl Icahn selling off significant stakes in Alphabet, Delta Air Lines, and Southwest Gas in Q1 2026, these stocks have continued their upward trajectory. This article explores the discrepancy between these high-profile exits and the persistent bullish sentiment from Wall Street analysts, examining the underlying data and fundamental strengths of each company to determine if retail investors should reconsider their positions.
By Ramit SethiJun 25, 2026
Money
Mirum Pharmaceuticals: A Potential Growth Story in Rare Diseases?
Mirum Pharmaceuticals is gaining attention as a promising entity in the rare disease sector, particularly following new data on its FOP treatment, zilurgisertib. Despite a Phase 2b study not meeting its primary endpoint, updated findings show encouraging clinical activity, prompting Citizens to raise its price target for MIRM. The company also recently granted inducement awards to new hires, aligning with its growth trajectory in developing therapies for liver and metabolic disorders caused by bile acid dysfunction.
By Bola SokunbiJun 25, 2026
Money
Upstream Bio: A Promising Biotech for Inflammatory Diseases
Upstream Bio, Inc. (NASDAQ: UPB) is gaining recognition as a potential opportunity in the biotech sector. Analyst Matthew Caufield initiated coverage with a 'Buy' rating and a $36 price target, highlighting the company's lead candidate, verekitug, an antibody targeting the thymic stromal lymphopoietin receptor. Recent Phase 2 trial results for verekitug in chronic rhinosinusitis with nasal polyps further support its potential, showing significant improvement and addressing an unmet medical need.
By Scott PapeJun 25, 2026
Money
Bed Bath & Beyond's Strategic Initiatives: Coupon Hunt and Home Services Expansion
Bed Bath & Beyond is actively working to rebuild customer engagement and expand its service offerings. The company recently launched a 'Legendary Coupon Hunt' to reconnect with long-time customers, offering a significant home transformation prize. Additionally, BBBY acquired Installed Right and SFV Services to bolster its home services platform, adding installation, renovation, and project management capabilities, which is expected to boost revenue and adjusted EBITDA.
By Dave RamseyJun 25, 2026